![Casey C. Kopczynski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Casey C. Kopczynski
Plus aucun poste en cours
Profil
Casey C.
Kopczynski was the founder of Aerie Pharmaceuticals, Inc. founded in 2005, where he held the title of Chief Innovation Officer in 2022.
He previously worked as Director-Research at Exelixis, Inc. from 1996 to 2002, Vice President-Research at Ercole Biotech, Inc. in 2003, and as Managing Partner at Biotech Initiative LLC from 2002 to 2005.
Dr. Kopczynski earned a doctorate degree from Indiana University.
Anciens postes connus de Casey C. Kopczynski
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Fondateur | 21/11/2022 |
Biotech Initiative LLC | Corporate Officer/Principal | - |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops splice switching drugs for the treatment of major human diseases | Directeur Technique/Scientifique/R&D | - |
| EXELIXIS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Formation de Casey C. Kopczynski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops splice switching drugs for the treatment of major human diseases | Commercial Services |
Biotech Initiative LLC |
